NCT00002639已完成2 期
ANALYSIS OF THE EFFICACY OF SURAMIN IN RECURRENT MALIGNANT PRIMARY BRAIN TUMORS
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of suramin in treating patients with recurrent primary brain tumors following radiation therapy.
详细描述
OBJECTIVES: I. Estimate the efficacy of suramin in patients with recurrent primary brain tumors as measured by radiographic response, time to progression, and survival. II. Assess the toxic effects of suramin in this patient population.
OUTLINE: Single-Agent Chemotherapy. Suramin, SUR, NSC-34936.
PROJECTED ACCRUAL: If at least 1 of the first 14 patients experiences at least a partial response, a total of 25 patients will be entered over approximately 30 months.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 15 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's DiseaseMultiple Myeloma and Plasma Cell NeoplasmNCT00002652University of Arkansas
已完成
1 期
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid TumorsUnspecified Adult Solid Tumor, Protocol SpecificBreast CancerProstate CancerColorectal CancerAdrenocortical CarcinomaNCT00003038Mayo Clinic
已完成
1 期
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyMultiple Myeloma and Plasma Cell NeoplasmSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol SpecificProstate CancerLymphomaLeukemiaNCT00005634Memorial Sloan Kettering Cancer Center
已完成
2 期
SarCNU in Treating Patients With Recurrent Malignant GliomaBrain and Central Nervous System TumorsNCT00036660NCIC Clinical Trials Group10
已完成
1 期
Chemotherapy in Treating Patients With Advanced Solid TumorsUnspecified Adult Solid Tumor, Protocol SpecificNCT00003703Jewish General Hospital